Business Insights: Pricing and Reimbursement Strategies for Diagnostics

Fair Value Pricing and Risk Sharing Pricing are the new methods of pricing within healthcare diagnostics. -Business Insights, 2010

The reimbursement for diagnostics is the key requirement for both the diagnostic providers and the payers because while 5-7% of the hospital cost is incurred on diagnostics, they are used for around 70% of the healthcare decisions.

This report identifies novel pricing strategies to maintain a fair plane among all the stakeholders.

Click here to view a sample of this report

This report will:

• Review regulatory structure for U.S. and Europe
• Evaluate existing pricing strategies for healthcare diagnostic equipments
• Review novel pricing strategies for healthcare diagnostic equipments
• Offer strategic recommendations for existing and first-mover healthcare diagnostic equipments
• Show indicative prices and reimbursement amounts for healthcare diagnostic equipments

This report will help you:

• Understand the existing structure for reimbursements for healthcare diagnostic equipments developed markets
• Understand the existing pricing for healthcare diagnostic equipments for developed markets
• Understand the role of various factors impacting price of the healthcare diagnostic equipments
• Understand the evolution of pricing strategies in recent times within healthcare diagnostic equipments
• Determine the complete understanding of changing times within pricing with respect to reimbursements

Key market issues discussed in this report:

• The healthcare diagnostic industry is currently facing the issue of lack of reimbursements for various procedures which are extremely critical to patient diagnosis
• This lack of reimbursements has started to affect the market negatively and the major markets in developed economies are seeing a negative to flat growth rate
• Various end users are using this opportunity to push the prices of the healthcare diagnostic products further down, which can lead to decrease in the size of the industry
• Various countries in Europe have their own reimbursement structure and policies with respect to various procedures. This is creating lot of bureacratic and pricing hurdles for the Original Equipment Manufacturers (OEMs) of these products.
• Various governments in Europe are changing their reimbursement policies with respect to new products launched within the healthcare diagnostic industry

Click here to view a sample of this report.

The report will be delivered as a PDF via e-mail. Orders must be paid in full before shipment. All sales are final; no returns or refunds are permitted with this product. For more information, please call 877/437-4276 or e-mail account manager Maureen Croce at mcroce@hcpro.com.

• Reports

• Other Life Sciences Products